AbbVie to Present at the Cowen 42nd Annual Health Care Conference

On March 1, 2022 AbbVie (NYSE: ABBV) reported that it will participate in the Cowen 42nd Annual Health Care Conference on Tuesday, March 8, 2021 (Press release, AbbVie, MAR 1, 2022, https://news.abbvie.com/news/press-releases/abbvie-to-present-at-cowen-42nd-annual-health-care-conference.htm [SID1234609249]). Robert A. Michael, vice chairman, finance and commercial operations and chief financial officer, Michael E. Severino, M.D., vice chairman and president, and Jeffrey R. Stewart, executive vice president, chief commercial officer, will present virtually at 11:50 a.m. Central Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.